|
CN111909906A
|
|
Urate oxidase modified by polyethylene glycol
|
|
CN110339345A
|
|
A kind of recombined human truncated-type keratinocyte growth factor-1 eye drops and its preparation method and application
|
|
CN110376369A
|
|
A kind of antigenic region Analysis of Immunogenicity method of anti-polyethylene glycol antibody
|
|
CN110305223A
|
|
The method that recombination fused in tandem albumen prepares target polypeptides
|
|
CN110183529A
|
|
A kind of recombination and preparation of deletion human keratinocyte growth factor-1
|
|
CN110118847A
|
|
Determine the analysis method in multidigit point PEG modification protein modification site
|
|
CN110066783A
|
|
A kind of nothing autotomys the MuPlm preparation method of form
|
|
CN109696554A
|
|
The detection method of Pegylation protein drug metabolite in a kind of quantitative analysis body
|
|
CN109682901A
|
|
The average degree of modification measuring method of Pegylation protein medicaments
|
|
CN109836487A
|
|
A kind of novel human desmocyte growth factor-21 8 and its soluble recombinant expression method, preparation method, preparation and application
|
|
CN109628436A
|
|
A kind of preparation method of fixed recombinant human arginase
|
|
CN109628533A
|
|
The soluble high efficiency recombinant expressed method of fibroblast growth factor albumen
|
|
CN109682963A
|
|
A method of analysis rh-insulin and the like or conjugate and insulin receptor Percentage bound
|
|
CN105085661A
|
|
Human glucagon-like peptide 2 (GLP-2C) pegylated homodimer and application thereof
|
|
CN105087724A
|
|
Preparation method for insulin aspart through recombinant expression by using yeast
|
|
CN105092490A
|
|
External biological activity determination method for human insulin and analog or conjugate
|
